Cargando…

Role of bile acids in inflammatory liver diseases

Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Evangelakos, Ioannis, Heeren, Joerg, Verkade, Esther, Kuipers, Folkert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443512/ https://www.ncbi.nlm.nih.gov/pubmed/34236487 http://dx.doi.org/10.1007/s00281-021-00869-6

Ejemplares similares

Bile Acid Sequestration via Colesevelam Reduces Bile Acid Hydrophobicity and Improves Liver Pathology in Cyp2c70(−/−) Mice with a Human-like Bile Acid Composition
por: Palmiotti, Anna, et al.
Publicado: (2023)

Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition
por: Verkade, Esther, et al.
Publicado: (2023)

Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases
por: Yntema, Tess, et al.
Publicado: (2023)

Inulin Supplementation Disturbs Hepatic Cholesterol and Bile Acid Metabolism Independent from Housing Temperature
por: Pauly, Mira J., et al.
Publicado: (2020)

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
por: Zhang, Boyan, et al.
Publicado: (2021)

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

Oxysterol 7-α Hydroxylase (CYP7B1) Attenuates Metabolic-Associated Fatty Liver Disease in Mice at Thermoneutrality
por: Evangelakos, Ioannis, et al.
Publicado: (2021)

Systems genetics approach reveals cross-talk between bile acids and intestinal microbes
por: Fu, Jingyuan, et al.
Publicado: (2019)

Therapeutic Roles of Bile Acid Signaling in Chronic Liver Diseases
por: Li, Yan, et al.
Publicado: (2018)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
por: Manley, Sharon, et al.
Publicado: (2015)

Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids
por: Way, Grayson W., et al.
Publicado: (2022)

Bile Acid Signaling in Inflammatory Bowel Disease
por: Bromke, Mariusz A., et al.
Publicado: (2021)

A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
por: Wang, Caihua, et al.
Publicado: (2019)

A Gas Chromatography Mass Spectrometry-Based Method for the Quantification of Short Chain Fatty Acids
por: Rohde, Julia K., et al.
Publicado: (2022)

Bile Acid Signaling in Inflammatory Bowel Diseases
por: Fiorucci, Stefano, et al.
Publicado: (2020)

Metabolic-associated fatty liver disease and lipoprotein metabolism
por: Heeren, Joerg, et al.
Publicado: (2021)

Bile Acid Signaling in Liver Metabolism and Diseases
por: Li, Tiangang, et al.
Publicado: (2012)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Bile Acids Activated Receptors in Inflammatory Bowel Disease
por: Biagioli, Michele, et al.
Publicado: (2021)

Bile Acids: Key Players in Inflammatory Bowel Diseases?
por: Kriaa, Aicha, et al.
Publicado: (2022)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

Glucose‐6‐Phosphate Regulates Hepatic Bile Acid Synthesis in Mice
por: Hoogerland, Joanne A., et al.
Publicado: (2019)

The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
por: Thomas, John P., et al.
Publicado: (2022)

Cold-Induced Lipoprotein Clearance in Cyp7b1-Deficient Mice
por: Evangelakos, Ioannis, et al.
Publicado: (2022)

Role of bile acids in liver diseases mediated by the gut microbiome
por: Shao, Jun-Wei, et al.
Publicado: (2021)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

The role of bile acids in carcinogenesis
por: Režen, Tadeja, et al.
Publicado: (2022)

The P2X7 ion channel is dispensable for energy and metabolic homeostasis of white and brown adipose tissues
por: Tian, Tian, et al.
Publicado: (2020)

Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity
por: Verhaag, Esther M., et al.
Publicado: (2016)

The Role of Bile Acids in the Human Body and in the Development of Diseases
por: Shulpekova, Yulia, et al.
Publicado: (2022)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

Bile acids and sphingolipids in non-alcoholic fatty liver disease
por: Jackson, Kaitlyn G., et al.
Publicado: (2022)

Low production of 12α-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70(−/−) mice by reducing fat absorption
por: Li, Rumei, et al.
Publicado: (2021)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023)

Plasma bile acids are not associated with energy metabolism in humans
por: Brufau, Gemma, et al.
Publicado: (2010)

The role of bile salts in liver regeneration
por: van de Laarschot, Liyanne F. M., et al.
Publicado: (2016)

Role of Endothelial Cell Lipoprotein Lipase for Brown Adipose Tissue Lipid and Glucose Handling
por: Thiemann, Ellen, et al.
Publicado: (2022)

Role of bile acids in colon carcinogenesis
por: Nguyen, Thi Thinh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j347sanbh0ctrlnkk4i0t5vglj